Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP8062 with Morphine in Recreational Opioid Users
NCT04448561Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in opioid use disorder (OUD) comparing ASP8062 + Morphine with Placebo + Morphine (2 arms). Primary endpoints: Number of Participants With Adverse Events (AEs), Number of Participants With At Least One Event of Suicidal Ideation And/or Suicidal Behavior and 2 more. Started Jun 2020; status: completed.
02
Drugs
ASP8062
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04448561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448561.